Abstract
Viral infection is a global health hazard. A crucial step in the infection cycle of enveloped viruses is the fusion of viral and host cellular membranes, which permits the transfer of the viral genome to the host cells. Membrane fusion is a ubiquitous process involved in sperm-egg fusion, exocytosis, vesicular trafficking, and viral entry to host cells. While different protein machineries catalyze the diverse fusion processes, the essential step, i.e., merging of two lipid bilayers against a kinetic energy barrier, is the same. Therefore, viral fusion machineries/pathways are not only the sites for antiviral drug development but also serve as model fusogens. Ensemble-based spectroscopic approaches or bulk fusion assays have yielded valuable insights regarding the fusion processes. However, due to the stochastic nature of the fusion events, ensemble-based assays do not permit synchronization of all the fusion events, and the molecular steps leading to fusion pore opening cannot be resolved entirely and correlated with the structural changes in viral fusion proteins. Several single-virus fusion assays have been developed to circumvent these issues. The review describes the recent advancements in single-virus/particle fusion assays using the Influenza virus as a paradigm.
Graphical Abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blumenthal R, Gallo SA, Viard M et al (2002) Fluorescent lipid probes in the study of viral membrane fusion. Chem Phys Lipids 116:39–55. https://doi.org/10.1016/s0009-3084(02)00019-1
Boonstra S, Blijleven JS, Roos WH et al (2018) Hemagglutinin-mediated membrane fusion: a biophysical perspective. Annu Rev Biophys 47:153–173. https://doi.org/10.1146/annurev-biophys-070317-033018
Brukman NG, Uygur B, Podbilewicz B, Chernomordik LV (2019) How cells fuse. J Cell Biol 218:1436–1451
Chao LH, Klein DE, Schmidt AG et al (2014) Sequential conformational rearrangements in flavivirus membrane fusion. Elife 3:e04389. https://doi.org/10.7554/eLife.04389
Chejanovsky N, Loyter A (1985) Fusion between Sendai virus envelopes and biological membranes. The use of fluorescent probes for quantitative estimation of virus-membrane fusion. J Biol Chem 260:7911–7918
Chernomordik L (1996) Non-bilayer lipids and biological fusion intermediates. Chem Phys Lipids 81:203–213. https://doi.org/10.1016/0009-3084(96)02583-2
Chernomordik LV, Kozlov MM (2008) Mechanics of membrane fusion. Nat Struct Mol Biol 15:675–683. https://doi.org/10.1038/nsmb.1455
Chernomordik L, Zimmerberg JV (1995) Bending membranes to the task: structural intermediates in bilayer fusion. Curr Opin Struct Biol 5:541–547. https://doi.org/10.1016/0959-440x(95)80041-7
Chlanda P, Zimmerberg J (2016) Protein-lipid interactions critical to replication of the influenza A virus. FEBS Lett 590:1940–1954. https://doi.org/10.1002/1873-3468.12118
Chlanda P, Mekhedov E, Waters H et al (2016) The hemifusion structure induced by influenza virus haemagglutinin is determined by physical properties of the target membranes. Nat Microbiol 1:16050. https://doi.org/10.1038/nmicrobiol.2016.50
Costello DA, Lee DW, Drewes J et al (2012) Influenza virus-membrane fusion triggered by proton uncaging for single particle studies of fusion kinetics. Anal Chem 84:8480–8489. https://doi.org/10.1021/ac3006473
Costello DA, Millet JK, Hsia CY et al (2013) Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers. Biomaterials 34:7895–7904. https://doi.org/10.1016/j.biomaterials.2013.06.034
Cross KJ, Langley WA, Russell RJ et al (2009) Composition and functions of the influenza fusion peptide. Protein Pept Lett 16:766–778. https://doi.org/10.2174/092986609788681715
Desai TM, Marin M, Chin CR et al (2014) IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog 10:e1004048. https://doi.org/10.1371/journal.ppat.1004048
Edinger TO, Pohl MO, Stertz S (2014) Entry of influenza A virus: host factors and antiviral targets. J Gen Virol 95:263–277. https://doi.org/10.1099/vir.0.059477-0
Espósito DLA, Nguyen JB, Dewitt DC et al (2015) Physico-chemical requirements and kinetics of membrane fusion of flavivirus-like particles. J Gen Virol 96:1702–1711. https://doi.org/10.1099/vir.0.000113
Floyd DL, Ragains JR, Skehel JJ et al (2008) Single-particle kinetics of influenza virus membrane fusion. Proc Natl Acad Sci U S A 105:15382–15387. https://doi.org/10.1073/pnas.0807771105
Haldar S, Mekhedov E, McCormick CD et al (2018) Lipid-dependence of target membrane stability during influenza viral fusion. J Cell Sci. https://doi.org/10.1242/jcs.218321
Haldar S, Okamoto K, Dunning RA, Kasson PM (2020) Precise triggering and chemical control of single-virus fusion within endosomes. J Virol. https://doi.org/10.1128/JVI.01982-20
Hamilton BS, Whittaker GR, Daniel S (2012) Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses 4:1144–1168. https://doi.org/10.3390/v4071144
Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15:690–698. https://doi.org/10.1038/nsmb.1456
Haywood AM (1974) Letter to the editor: fusion of Sendai viruses with model membranes. J Mol Biol 87:625–628. https://doi.org/10.1016/0022-2836(74)90107-7
Ivanovic T, Harrison SC (2015) Distinct functional determinants of influenza hemagglutinin-mediated membrane fusion. Elife 4:e11009. https://doi.org/10.7554/eLife.11009
Ivanovic T, Rozendaal R, Floyd DL et al (2012) Kinetics of proton transport into influenza virions by the viral M2 channel. PLoS ONE 7:e31566. https://doi.org/10.1371/journal.pone.0031566
Ivanovic T, Choi JL, Whelan SP et al (2013) Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. Elife 2:e00333. https://doi.org/10.7554/eLife.00333
Jamjian MC, McNicholl IR (2004) Enfuvirtide: first fusion inhibitor for treatment of HIV infection. Am J Health Syst Pharm 61:1242–1247. https://doi.org/10.1093/ajhp/61.12.1242
Kadam RU, Wilson IA (2017) Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc Natl Acad Sci U S A 114:206–214. https://doi.org/10.1073/pnas.1617020114
Lakadamyali M, Rust MJ, Babcock HP, Zhuang X (2003) Visualizing infection of individual influenza viruses. Proc Natl Acad Sci U S A 100:9280–9285. https://doi.org/10.1073/pnas.0832269100
Lam A, Kirkland OO, Anderson PF et al (2022) Single-virus assay reveals membrane determinants and mechanistic features of Sendai virus binding. Biophys J 121:956–965. https://doi.org/10.1016/j.bpj.2022.02.011
Lee KK (2010) Architecture of a nascent viral fusion pore. EMBO J 29:1299–1311. https://doi.org/10.1038/emboj.2010.13
Leikin S, Parsegian VA, Rau DC, Rand RP (1993) Hydration forces. Annu Rev Phys Chem 44:369–395. https://doi.org/10.1146/annurev.pc.44.100193.002101
Liu KN, Boxer SG (2020) Target membrane cholesterol modulates single influenza virus membrane fusion efficiency but not rate. Biophys J 118:2426–2433. https://doi.org/10.1016/j.bpj.2020.03.021
Liu KN, Boxer SG (2021) Single-virus content-mixing assay reveals cholesterol-enhanced influenza membrane fusion efficiency. Biophys J 120:4832–4841. https://doi.org/10.1016/j.bpj.2021.09.023
Malinin VS, Frederik P, Lentz BR (2002) Osmotic and curvature stress affect PEG-induced fusion of lipid vesicles but not mixing of their lipids. Biophys J 82:2090–2100
Menéndez-Arias L, Richman DD (2014) Editorial overview: antivirals and resistance: advances and challenges ahead. Curr Opin Virol 8:4–7. https://doi.org/10.1016/j.coviro.2014.08.002
Niles WD, Cohen FS. (1991) Fusion of influenza virions with a planar lipid membrane detected by video fluorescence microscopy. J Gen Physiol. 97:1101–1119. https://doi.org/10.1085/jgp.97.6.1101
Nussbaum O, Lapidot M, Loyter A (1987) Reconstitution of functional influenza virus envelopes and fusion with membranes and liposomes lacking virus receptors. J Virol 61:2245–2252. https://doi.org/10.1128/JVI.61.7.2245-2252.1987
Pabis A, Rawle RJ, Kasson PM (2020) Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms. Proc Natl Acad Sci U S A 117:7200–7207. https://doi.org/10.1073/pnas.1914188117
Park A, Graceffa O, Rawle RJ (2020) Kinetic modeling of west nile virus fusion indicates an off-pathway state. ACS Infect Dis 6:3260–3268. https://doi.org/10.1021/acsinfecdis.0c00637
Rawle RJ, Boxer SG, Kasson PM (2016) Disentangling viral membrane fusion from receptor binding using synthetic DNA-lipid conjugates. Biophys J 111:123–131. https://doi.org/10.1016/j.bpj.2016.05.048
Rawle RJ, Webster ER, Jelen M et al (2018) pH dependence of Zika membrane fusion kinetics reveals an off-pathway state. ACS Cent Sci 4:1503–1510. https://doi.org/10.1021/acscentsci.8b00494
Rawle RJ, Villamil Giraldo AM, Boxer SG, Kasson PM (2019) Detecting and controlling dye effects in single-virus fusion experiments. Biophys J 117:445–452. https://doi.org/10.1016/j.bpj.2019.06.022
Rossman JS, Leser GP, Lamb RA (2012) Filamentous influenza virus enters cells via macropinocytosis. J Virol 86:10950–10960. https://doi.org/10.1128/JVI.05992-11
Rust MJ, Lakadamyali M, Zhang F, Zhuang X (2004) Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 11:567–573. https://doi.org/10.1038/nsmb769
Segev N, Avinoam O, Podbilewicz B (2018) Fusogens. Curr Biol 28:R378–R380
Shangguan T, Alford D, Bentz J (1996) Influenza-virus-liposome lipid mixing is leaky and largely insensitive to the material properties of the target membrane. Biochemistry 35:4956–4965. https://doi.org/10.1021/bi9526903
Shangguan T, Siegel DP, Lear JD et al (1998) Morphological changes and fusogenic activity of influenza virus hemagglutinin. Biophys J 74:54–62. https://doi.org/10.1016/S0006-3495(98)77766-5
Tsurudome M, Gluck R, Graf R et al (1992) Lipid interactions of the hemagglutinin HA2 NH2-terminal segment during influenza virus-induced membrane fusion. J Biol Chem 267:20225–20232. https://doi.org/10.1016/s0021-9258(19)88690-8
van der Schaar HM, Rust MJ, Chen C et al (2008) Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4:e1000244. https://doi.org/10.1371/journal.ppat.1000244
Vigant F, Santos NC, Lee B (2015) Broad-spectrum antivirals against viral fusion. Nat Rev Microbiol 13:426–437
Villamil Giraldo AM, Kasson PM (2020) Bilayer-coated nanoparticles reveal how influenza viral entry depends on membrane deformability but not curvature. J Phys Chem Lett 11:7190–7196. https://doi.org/10.1021/acs.jpclett.0c01778
Villamil Giraldo AM, Mannsverk S, Kasson PM (2022) Measuring single-virus fusion kinetics using an assay for nucleic acid exposure. BioRxiv. https://doi.org/10.1101/2022.05.20.492704
Webster ER, Liu KN, Rawle RJ, Boxer SG (2022) Modulating the influenza A virus-target membrane fusion interface with synthetic DNA-lipid receptors. Langmuir 38:2354–2362. https://doi.org/10.1021/acs.langmuir.1c03247
Wei C-J, Crank MC, Shiver J et al (2020) Next-generation influenza vaccines: opportunities and challenges. Nat Rev Drug Discov 19:239–252. https://doi.org/10.1038/s41573-019-0056-x
Wessels L, Elting MW, Scimeca D, Weninger K (2007) Rapid membrane fusion of individual virus particles with supported lipid bilayers. Biophys J 93:526–538. https://doi.org/10.1529/biophysj.106.097485
White J, Helenius A (1980) pH-dependent fusion between the Semliki forest virus membrane and liposomes. Proc Natl Acad Sci U S A 77:3273–3277. https://doi.org/10.1073/pnas.77.6.3273
White JM, Whittaker GR (2016) Fusion of enveloped viruses in endosomes. Traffic 17:593–614. https://doi.org/10.1111/tra.12389
Wolf MC, Freiberg AN, Zhang T et al (2010) A broad-spectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci U S A 107:3157–3162. https://doi.org/10.1073/pnas.0909587107
Acknowledgements
SH acknowledges the Department of Biotechnology, Govt. of India for the Ramalingaswami Fellowship and the Division of Virus Research and Therapeutics, CSIR-Central Drug Research Institute, Lucknow, India, for institutional support. SH thanks Peter Kasson for introducing him to the single-virus fusion assay CSIR-CDRI communication number 10460.
Author information
Authors and Affiliations
Contributions
SH wrote the whole manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declares that the author has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Haldar, S. Recent Developments in Single-Virus Fusion Assay. J Membrane Biol 255, 747–755 (2022). https://doi.org/10.1007/s00232-022-00270-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-022-00270-w